Clinical Trials in New York State

Showing 3001-3020 of 14,718 trials

Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia

NCT04675151

The objectives of this study are: To evaluate the efficacy of Nyxol + Pilocarpine to improve DCNVA in subjects with presbyopia

Presbyopia

Ocuphire Pharma, Inc.150 participantsStarted Feb 2021

Laguna Hills, California, United States • Newport Beach, California, United States • Crystal River, Florida, United States +14 more locations

Active Not RecruitingPhase 369 miles

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

NCT03887455

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiority of lecanemab compared with placebo on the change from baseline in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) at 18 months of treatment in the Core Study. This study will also evaluate the long-term safety and tolerability of lecanemab in participants with EAD in the Extension Phase and whether the long-term effects of lecanemab as measured by the CDR-SB at the end of the Core Study is maintained over time in the Extension Phase. Extension Phase Part B will continue dosing with lecanemab in countries where lecanemab may not be commercially available.

Early Alzheimer's Disease

Eisai Inc.1,906 participantsStarted Mar 2019

Phoenix, Arizona, United States • Sun City, Arizona, United States • Tucson, Arizona, United States +244 more locations

Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

Find Trials by Condition in New York State

Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen

Intent of Surgery for IPMN

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment

Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy

The Periviable GOALS Decision Support Tool

Effects of Long-Duration Spaceflight on General and Spatial Cognition and Its Neural Basis

A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors

RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy

A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life

HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)

An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease